Shenzhen Neptunus Bioengineering Balance Sheet Health
Financial Health criteria checks 4/6
Shenzhen Neptunus Bioengineering has a total shareholder equity of CN¥4.2B and total debt of CN¥11.0B, which brings its debt-to-equity ratio to 261.4%. Its total assets and total liabilities are CN¥31.3B and CN¥27.1B respectively. Shenzhen Neptunus Bioengineering's EBIT is CN¥516.6M making its interest coverage ratio 0.6. It has cash and short-term investments of CN¥3.4B.
Key information
261.4%
Debt to equity ratio
CN¥10.95b
Debt
| Interest coverage ratio | 0.6x |
| Cash | CN¥3.39b |
| Equity | CN¥4.19b |
| Total liabilities | CN¥27.13b |
| Total assets | CN¥31.32b |
Recent financial health updates
Recent updates
Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Revenues Are Not Doing Enough For Some Investors
Oct 28
Here's Why Shenzhen Neptunus Bioengineering (SZSE:000078) Is Weighed Down By Its Debt Load
Jul 15There Is A Reason Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Price Is Undemanding
Jun 07Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Share Price Is Matching Sentiment Around Its Revenues
Mar 05Financial Position Analysis
Short Term Liabilities: 000078's short term assets (CN¥27.8B) exceed its short term liabilities (CN¥26.7B).
Long Term Liabilities: 000078's short term assets (CN¥27.8B) exceed its long term liabilities (CN¥436.9M).
Debt to Equity History and Analysis
Debt Level: 000078's net debt to equity ratio (180.6%) is considered high.
Reducing Debt: 000078's debt to equity ratio has increased from 146.7% to 261.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 000078 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 000078 has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 12.4% each year.